English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Neo-epitope tissue transglutaminase autoantibodies as a biomarker of the gluten sensitive skin disease - Dermatitis herpetiformis

Lytton, S. D., Antiga, E., Pfeiffer, S., Matthias, T., Szaflarska-Poplawska, A., Ulaganathan, V. K., et al. (2013). Neo-epitope tissue transglutaminase autoantibodies as a biomarker of the gluten sensitive skin disease - Dermatitis herpetiformis. CLINICA CHIMICA ACTA, 415, 346-349. doi:10.1016/j.cca.2012.10.051.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Lytton, Simon D.1, Author
Antiga, Emiliano1, Author
Pfeiffer, Sascha1, Author
Matthias, Torsten1, Author
Szaflarska-Poplawska, Anna1, Author
Ulaganathan, Vijay Kumar2, Author           
Placek, Waldemar1, Author
Fabbri, Paolo1, Author
Hall, Russell1, Author
Caproni, Marzia1, Author
Affiliations:
1external, ou_persistent22              
2Ullrich, Axel / Molecular Biology, Max Planck Institute of Biochemistry, Max Planck Society, ou_1565172              

Content

show
hide
Free keywords: CELIAC-DISEASE; PEDIATRIC-GASTROENTEROLOGY; ANTIBODIES; DIAGNOSIS; HEPATOLOGY; NUTRITION; ELISA; IGGDermatitis herpetiformis; Neoepitope tissue transglutaminase; Deamidated gliadin peptides; Gluten-sensitive disease; ELISA;
 Abstract: Background: The deamidated gliadin peptides (DGP) cross linked to human tissue transglutaminase (tTg) comprises a novel neo-epitope structure (Neo-tTg) for serological screening of celiac disease (CD). Our aim is to verify anti-Neo-tTg IgA and IgG in adults with dermatitis herpetiformis (DH). Methods: Multi-centric retrospective evaluation of the IgA/G autoantibodies in sera of DH patients on a regular diet (n=40) and a gluten restricted diet (GRD, n=53) and control adults with autoimmune skin diseases (n=107) by ELISA. Results: The sensitivities of Celicheck Neo IgA/G (76%, 95% CI 67-84%) and the Neo tTg-A (85%, 95% CI 70-97%) ELISA were significantly greater than that of tTg-A (56%, 95% CI 46-67%), eTg-A (62%, 95% CI 52-72%), DGP-A (55%, 95% CI 55-65%), DGP-G (61%, 95% CI 51-71%), Glia-A (55%, 95% CI 45-65%) and Glia-G (56%, 95% CI 46-66%) ELISA. The specificities of all 8 ELISA were in the range of 90-100%. The area under the curve (AUC) of receiver operator characteristic curve (ROC) for the two Neo-tTg ELISA (0.863 and 0.949) were higher than the AUCs for ROCs of tTg, DGP and eTG ELISA (range between 0.657 and 0.783). The autoantibody levels of DH patients on a normal diet were significantly higher than those on GRD in the Celicheck Neo IgA/IgG, NeotTg-A; tTg-A and the eTg-A; ELISA (p<0.01) and of no significance in the DGP and Gliadin ELISA. Conclusion: Neo-epitope IgA autoantibodies represent a new and sensitive sbrological marker of DH. (C) 2012 Elsevier B.V. All rights reserved.

Details

show
hide
Language(s): eng - English
 Dates: 2013-01-16
 Publication Status: Published in print
 Pages: 4
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: ISI: 000314901900064
DOI: 10.1016/j.cca.2012.10.051
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: CLINICA CHIMICA ACTA
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS : ELSEVIER SCIENCE BV
Pages: - Volume / Issue: 415 Sequence Number: - Start / End Page: 346 - 349 Identifier: ISSN: 0009-8981